Zobrazeno 1 - 10
of 83
pro vyhledávání: '"G J, Bosl"'
Autor:
G J Bosl
Publikováno v:
Journal of Clinical Oncology. 16:1244-1247
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb36e16571c4e74ae539d2a1c4f01233
https://doi.org/10.1200/jco.1998.16.4.1244
https://doi.org/10.1200/jco.1998.16.4.1244
Publikováno v:
JAMA. 286(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c1b82e644738e93b03786041acc469b
https://pubmed.ncbi.nlm.nih.gov/11559283
https://pubmed.ncbi.nlm.nih.gov/11559283
Autor:
M J, Morris, G J, Bosl
Publikováno v:
The Journal of urology. 163(3)
The judicious use of serum alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and lactate dehydrogenase is key to appropriate management of patients with germ cell tumors. Elevated AFP and/or HCG generally indicate active disease. We describ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::54fbd1ebf7215d1fd3418a0fe40fa661
https://pubmed.ncbi.nlm.nih.gov/11203071
https://pubmed.ncbi.nlm.nih.gov/11203071
Autor:
M J, Morris, G J, Bosl
Publikováno v:
International journal of cancer. 83(6)
Although the majority of patients with poor-risk germ-cell tumors (GCTs) will achieve a durable complete remission (CR) with standard first-line therapy, 20% to 30% of them will either relapse or fail to achieve an initial CR and eventually die. For
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::363d5be6aba7cb8b309e5138820cd863
https://pubmed.ncbi.nlm.nih.gov/10597205
https://pubmed.ncbi.nlm.nih.gov/10597205
Autor:
G J, Bosl
Publikováno v:
Seminars in surgical oncology. 17(4)
The management of germ cell tumors (GCT) in men has been the focus of intense clinical investigation over the past 25 years. Following clinical trials which demonstrated that GCTs are curable, considerable effort has been directed at refinement of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7cfc257e187e5b958e500398ecdb012f
https://pubmed.ncbi.nlm.nih.gov/10588854
https://pubmed.ncbi.nlm.nih.gov/10588854
Autor:
G J, Bosl, K F, Malbin
Publikováno v:
Oncology (Williston Park, N.Y.). 11(11A)
Memorial Sloan-Kettering Cancer Center staff, in conjunction with Cambridge Technology Partners, has designed, developed, and begun to implement a disease management system (DMS) as a means of standardizing the care of the center's patients with canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::29e551fd15704fe3dac0319a6d63142b
https://pubmed.ncbi.nlm.nih.gov/9430177
https://pubmed.ncbi.nlm.nih.gov/9430177
Publikováno v:
Oncology (Williston Park, N.Y.). 11(9 Suppl 9)
Radical cystectomy remains standard management for patients with locally advanced T2 through T4, N0, M0 transitional cell carcinoma of the urinary bladder. Although radical cystectomy results in excellent local control, 50% or more of patients relaps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c4aa15dbf2c88523f60c75505f6f6fb7
https://pubmed.ncbi.nlm.nih.gov/9330404
https://pubmed.ncbi.nlm.nih.gov/9330404
Publikováno v:
Cell growthdifferentiation : the molecular biology journal of the American Association for Cancer Research. 8(3)
Human male germ cell tumors (GCTs) arise in the spermatocytic lineage, and subsets display embryonal-like differentiation. Virtually all GCTs exhibit multiple copies of the short arm of chromosome 12, even in carcinoma in situ/intratubular germ cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7994501703cb853ea16859a776107f45
https://pubmed.ncbi.nlm.nih.gov/9056671
https://pubmed.ncbi.nlm.nih.gov/9056671
Autor:
H W, Herr, J, Sheinfeld, H S, Puc, R, Heelan, D F, Bajorin, P, Mencel, G J, Bosl, R J, Motzer
Publikováno v:
The Journal of urology. 157(3)
We attempted to select patients for surgery of post-chemotherapy residual mass in advanced seminoma.A total of 55 patients with advanced seminoma underwent surgical exploration of a mass seen on computerized tomography (CT) after chemotherapy. Residu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8451dd2cc835e8640a0c7d07d17e65c3
https://pubmed.ncbi.nlm.nih.gov/9072586
https://pubmed.ncbi.nlm.nih.gov/9072586
Publikováno v:
Current therapy in endocrinology and metabolism. 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::579d6aff8f7f7ac374cd66dadca7baf9
https://pubmed.ncbi.nlm.nih.gov/9174777
https://pubmed.ncbi.nlm.nih.gov/9174777